An Integrated Approach to Visual Health and Medication Safety: Combining Optometric Assessment, Ocular Disease Screening, Pharmacological Management, and the Prevention of Drug-Related Visual Complications

Authors

  • Ahmed Attiyah Alharbi, Shari Thawab Alqahtani, Heba Mohammad Qunq, Abdulsalam Hassan H Abu Sulayman, Ibrahim Dawy Alotiaibi
  • Amin Amir Turkestani, Abedullah Mohammed Alkhateeb, Hasan Abdulaziz Ghurab, Abdulaziz Mousa Alzahrani, Abdulkareem Yahya Abdulfattah Alqbli

DOI:

https://doi.org/10.70082/0hsrtb60

Keywords:

optometry; vision screening; ocular toxicity; medication safety; drug monitoring; interprofessional care

Abstract

Background: Reduced vision may reflect refractive error, ocular disease, or a medication effect. Screening and prescribing often take place in different services, creating opportunities for missed referrals or overdue monitoring. Objective: To synthesize evidence on how eye care and pharmacy teams can integrate ocular disease screening, pharmacological management, and prevention of medication-related visual complications in adult care. Methods: Targeted literature searches identified guidelines, systematic reviews, trials, and observational studies published through December 2024. Selected drug safety warnings were checked against dated regulatory documents. Results: Diabetes warrants scheduled retinal assessment even when vision is normal. Glaucoma evaluation requires interpretation of pressure, optic nerve findings, and visual fields in context. Safe ophthalmic prescribing depends on the indication, systemic contraindications, and the patient’s ability to use drops. Hydroxychloroquine, ethambutol, topiramate, corticosteroids, and pentosan polysulfate illustrate distinct patterns of harm that require different surveillance and responses. Conclusion: Integration is most useful when teams share a medication history, specify which test is needed and when, and verify that referrals and abnormal results lead to action. Acute symptoms require timely assessment, while equivocal surveillance findings should be confirmed before altering otherwise beneficial treatment.

Downloads

Published

2024-04-10

Issue

Section

Articles

How to Cite

An Integrated Approach to Visual Health and Medication Safety: Combining Optometric Assessment, Ocular Disease Screening, Pharmacological Management, and the Prevention of Drug-Related Visual Complications. (2024). The Review of Diabetic Studies , 801-808. https://doi.org/10.70082/0hsrtb60